Compare
Gilead Sciences vs Vericel (GILD vs VCEL)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Gilead Sciences (GILD) returned +36.1% and Vericel (VCEL) +46.8%; so far this year the figures are +36.0% and +51.7%.
Gilead Sciences is the larger company by market value, about 74.2 times the size of Vericel.
Revenue grew +6.5% at GILD and +25.3% at VCEL over the last year.
GILD yields 1.95%. VCEL pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| GILD | VCEL | |
|---|---|---|
| Price | $166.89 | $54.62 |
| 1-day | -0.41% | +5.48% |
| YTD | +35.97% | +51.68% |
| 1 year | +36.15% | +46.83% |
| 3 years | +108.12% | +56.06% |
| Market cap | $207.0B | $2.8B |
| P/E | — | 85.3 |
| P/S | 6.68 | 8.60 |
| P/B | 15.87 | 7.26 |
| Revenue growth | +6.50% | +25.30% |
| EPS growth | -149.00% | +156.00% |
| Gross margin % | 79.9 | 74.5 |
| Net margin % | -12.5 | 10.3 |
| ROE % | -29.6 | 8.7 |
| Debt / equity | 2.01 | 0.03 |
| FCF yield % | 6.7 | 2.1 |
| Dividend yield % | 1.95 | — |
| Beta | 0.37 | 0.43 |
| RSI (14) | 60.2 | 78.4 |
| Technical rating |